OR8I2 inhibitors are a class of chemical compounds that specifically target and inhibit the function of the **OR8I2** protein, a member of the olfactory receptor family, which is part of the G protein-coupled receptor (GPCR) superfamily. These inhibitors work by binding to specific regions of the OR8I2 receptor, preventing it from interacting with its natural ligands or substrates. OR8I2, like other olfactory receptors, may play a role in detecting chemical signals, triggering intracellular pathways related to cellular responses or signaling processes. By blocking OR8I2's function, researchers can investigate its specific role in signal transduction pathways, exploring how the receptor influences cellular communication, molecular recognition, and its interactions with other proteins or signaling molecules.
The use of OR8I2 inhibitors is important in studying the broader biological and molecular mechanisms involved in receptor-mediated signaling. Inhibition of OR8I2 can reveal how the protein fits into larger networks of GPCR-related processes, such as ligand binding, signal amplification, or downstream regulatory activities. Additionally, these inhibitors can help researchers explore the potential feedback mechanisms that may arise when the receptor's function is disrupted, offering insights into how cells compensate for the loss of specific olfactory receptor activity. Through the study of OR8I2 inhibitors, scientists can gain a deeper understanding of the molecular pathways that regulate receptor function and their implications in broader cellular processes, such as metabolism, communication, or environmental response. This research helps elucidate the critical role that olfactory receptors like OR8I2 play in maintaining cellular homeostasis and orchestrating complex molecular interactions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A might inhibit the acetylation of histones near the OR8I2 gene, potentially leading to a condensed chromatin state and decreased OR8I2 transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By incorporating into DNA, 5-Azacytidine could decrease methylation levels at the OR8I2 promoter, leading to a reduction in OR8I2 gene transcription. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D could bind specifically to the DNA of the OR8I2 gene and block RNA polymerase movement, leading to a direct decrease in OR8I2 mRNA synthesis. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin might selectively reduce OR8I2 expression by inhibiting the mTOR pathway, which is often involved in the control of protein synthesis and gene expression patterns. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin could directly inhibit RNA polymerase II activity during OR8I2 gene transcription, resulting in a decrease in OR8I2 mRNA production. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
By binding to specific DNA sequences, Mithramycin A might disrupt transcription factor binding necessary for OR8I2 expression, leading to downregulation of the OR8I2 gene. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine could intercalate into DNA and RNA, which might cause a decrease in the OR8I2 gene's transcriptional efficiency, resulting in less OR8I2 protein being synthesized. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide might repress the transcription of the OR8I2 gene by inhibiting the activity of transcription factors or the assembly of the transcriptional machinery at the OR8I2 locus. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 could disrupt the interaction between bromodomain-containing proteins and acetylated histones at the OR8I2 promoter, leading to a decrease in OR8I2 expression. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $317.00 | ||
Flavopiridol might inhibit cyclin-dependent kinases necessary for RNA polymerase II phosphorylation, leading to a decrease in OR8I2 mRNA transcription. | ||||||